Misc

How to get ACCME Reaccreditation: Advice

Sep 19th, 2011 | By

Reaccreditation can be an exacting process. Has your company/institution gone through the process recently? Do you have advice to share to smooth the way for others? Please leave a comment below with your advice to earn the CME community’s undying gratitude.

Share


CME Message: Prescribe More EMSAM!

Sep 9th, 2011 | By

MAOIs are tricky to prescribe. Are they really worth the risks of drug and food interactions? Are they actually more effective than SSRIs for atypical depression? These are tough questions to answer. Do you trust two MECCs paid by the maker of EMSAM to give you accurate answers? God help your patients if you do.
[continue reading...]

Share


Pseudo CME about Pseudobulbar Affect

Sep 9th, 2011 | By

Stephen Stahl’s company NEI (Neuroscience Institute) produces plenty of good psychiatric education, much of it funded by subscription fees paid by doctors. But the more lucrative part of their business is churning out industry-supported CME. This is an activity funded by Avanir, maker of Nuedexta. Based on a “real patient case,” the course describes a
[continue reading...]

Share


From the Rogue’s Gallery Archives—Delaware Media Group: Sleazy MECC of the Month

Sep 9th, 2011 | By

The June 2010 issue of “Counseling Points” was body-snatched by Janssen Pharmaceuticals, and became an ACCME accredited advertisement for Risperdal Consta and Invega Sustenna. See the Carlat Psychiatry Blog exposè here.

Share


CME Rogue’s Gallery Nomination Page

Sep 9th, 2011 | By

Have you run across an accredited CME course that is so blatantly promotional that you find yourself getting queasy? Please tell us about it. We’ll investigate it, and if it meets our criteria for promotional CME, we may very well post it on our official CME Rogue’s Gallery page—and we will acknowledge you if you
[continue reading...]

Share